[(18)F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study. Chan DL, Hayes A, Karfis I, Conner A, et al. J Nucl Med 2025;66:1012-1017.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chan DL, Hayes A, Karfis I, Conner A, et al. [(18)F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study. J Nucl Med 2025;66:1012-1017.
PMID: 40404400